GlaxoSmithKline's Anoro tops Boehringer's Stiolto in head-to-head COPD tilt
admin 3rd November 2017 Uncategorised 0The LAMA/LABA market is a crowded one, but GlaxoSmithKline has some new data in hand that it hopes can give it a leg up on a Boehringer Ingelheim rival.
More: GlaxoSmithKline's Anoro tops Boehringer's Stiolto in head-to-head COPD tilt
Source: fierce